- Home
- VTS vs RGNX Comparison
VTS vs RGNX Comparison
Compare VTS & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VTS | RGNX |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 740.2M | 761.9M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | VTS | RGNX |
|---|---|---|
| Price | $19.33 | $13.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $26.50 | ★ $30.78 |
| AVG Volume (30 Days) | 409.6K | ★ 696.9K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | ★ 11.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.56 | N/A |
| Revenue | ★ $248,169,000.00 | $161,318,000.00 |
| Revenue This Year | $29.38 | $133.58 |
| Revenue Next Year | N/A | $45.08 |
| P/E Ratio | $34.45 | ★ N/A |
| Revenue Growth | 6.73 | ★ 91.30 |
| 52 Week Low | $18.85 | $5.04 |
| 52 Week High | $27.49 | $15.84 |
Technical Indicators
Market Signals| Indicator | VTS | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 41.36 | 46.45 |
| Support Level | $18.85 | $14.53 |
| Resistance Level | $20.31 | $15.31 |
| Average True Range (ATR) | 0.52 | 0.89 |
| MACD | 0.09 | -0.13 |
| Stochastic Oscillator | 28.33 | 24.58 |
Price Performance
Historical ComparisonAbout VTS Vitesse Energy Inc.
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.